Related Experiment Video
Updated: Aug 26, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children
Andrea Kosch1, Hans Georg Koch, Achim Heinecke
1Department of Pediatric Hematology/Oncology, University Children's Hospital Münster, Germany. koscha@uni-muenster.de
Insights
Elevated total homocysteine (tHcy) is a risk factor for blood clots in children. Studies show higher tHcy levels in pediatric patients with thromboembolic events, suggesting screening is recommended.
Area of Science:
- Pediatric Thrombosis
- Clinical Biochemistry
- Cardiovascular Research
Background:
- Elevated total homocysteine (tHcy) is a known risk factor for thromboembolic events in adults.
- Data on hyperhomocysteinemia in pediatric patients with thromboembolism are limited.
- This study investigates the association between tHcy levels and thromboembolic events in children.
Purpose of the Study:
- To determine if elevated fasting total homocysteine (tHcy) levels are associated with an increased risk of thromboembolic events in pediatric patients.
- To compare tHcy levels in children with a first symptomatic thromboembolic event to those in healthy controls.
- To establish the clinical significance of hyperhomocysteinemia in childhood thromboembolism.
Main Methods:
- A case-control study was conducted involving 163 pediatric patients with a first symptomatic thromboembolic event and 255 healthy controls.
- Participants' ages ranged from 3 months to 18 years.
- Fasting total homocysteine (tHcy) levels were measured and compared between the patient and control groups, with analysis of age-specific 90th percentiles and odds ratios.
Main Results:
- Median tHcy levels were significantly higher in pediatric patients with thromboembolism (6.6 micromol/l) compared to healthy controls (5.7 micromol/l) (p<0.0001).
- 29.5% of patients had tHcy levels above the age-specific 90th percentile, versus 10.2% of controls (OR 2.9).
- Children in the highest quintile of tHcy had a 4.3 times higher odds of thromboembolic disease compared to those in the lowest quintile, indicating risk even with mild hyperhomocysteinemia.
Conclusions:
- Hyperhomocysteinemia, even at mild levels above age-specific cut-offs, is a significant risk factor for thromboembolic events in children.
- Screening for elevated fasting tHcy levels in pediatric patients with thromboembolism is recommended for risk stratification.
- These findings highlight the importance of assessing tHcy in the pediatric population presenting with thromboembolic conditions.
Abstract:
Elevated total homocysteine (tHcy) concentrations are an independent risk factor for thromboembolic events in adults. In children with moderate hyperhomocysteinemia data are sparse. Therefore, between 1995 and 2002 we consecutively recruited 163 white pediatric patients with a first symptomatic thromboembolic event and 255 healthy controls (mean age: 6.4 years in patients vs. 6.6 years in controls, range: 3 months to 18 years) and measured fasting tHcy levels. Median tHcy levels in patients were significantly higher (6.6 micromol/l, range 2.9-20.4 micromol/l) than in controls (5.7 micromol/l, 2.0-14.0 micromol/l, p<0.0001). 48 of the 163 patients with thromboembolism (29.5%) versus 26 of the 255 controls (10.2%) had tHcy levels above the age-specific normal 90th percentile (OR 2.9, 95%CI: 1.7-4.8). The odds ratio for children in the highest quintile compared to children with levels in the lowest quintile was 4.3 (1.6-8.1; highest quintile: median tHcy level 9.6 micromol, range 8.0-20.4), showing a significantly increased risk for thromboembolic disease with even mild hyperhomocysteinemia. We conclude that hyperhomocysteinemia above the age-specific cut-off values is a risk factor for thromboembolic events in children. Therefore, screening for elevated fasting tHcy levels of patients with thromboembolism is recommended to stratify the risk of thromboembolism.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cholesterol: Significance and Regulation
Considering cholesterol and...